Technology Roundup – Tesla launches its Indian unit in Bengaluru; names three directors; Alibaba and Foxconn the latest to charge into the electric vehicle world Technology
Healthcare Roundup – Gilead and VIR Biotechnology tie up in chronic hepatitis B virus cure setting, AstraZeneca’s COVID-19 vaccine is set for Indian rollout Life Science
Technology Roundup – Apple sells 18M iPhone 12 units in China in Q4; Tesla pulled an Apple move in self-driving, leaving Apple Car ‘way behind’ Technology
Healthcare Roundup – JNJ’s single-dose COVID-19 vaccine viewed favorably by analysts; Eli Lilly up 20% after donanemab shows clinical benefit in mid-stage Alzheimer’s study Life Science
Technology Roundup – CES 2021 kicks off in cyberspace in blow to Las Vegas, Facebook has ‘no plans’ to permit Trump back on platform Technology
Healthcare Roundup – CVS raised as Jefferies sees meaningful earning surprises; SoftBank takes stake in Pacific Biosciences Life Science
Technology Roundup – Twitter permanently bans President Trump’s account; Intel reportedly talking with TSMC and Samsung Technology
Healthcare Roundup – Roche/Sanofi treatment combo improves survival rates in COVID-19；Dynavax’s Hepatitis B vaccine shows encouraging action in ongoing hemodialysis trial Life Science
Technology Roundup – Apple and Hyundai in talks over electric vehicle partnership, Baidu may raise $3.5B in Hong Kong listing Technology
Healthcare Roundup – Pfizer taps Dewpoint Therapeutics in $239M dystrophy candidate pact；Gilead’s Kite, Oxford BioTherapeutics ink immuno-oncology pact Life Science
Technology Roundup – Apple beats financial targets，Trump moves to bans Alipay and other Chinese payment apps Technology
Technology Roundup – Alibaba cut to Sell by CFRA as regulations continue to tighten in China, Apple lands higher estimates at Canaccord due to iPhone 12 strength Technology
Healthcare Roundup – Moderna’s COVID-19 vaccine authorized in Israel; Moderna and NIH to study the effects of halving the COVID-19 shot Life Science
Healthcare Roundup – EU regulator remains undecided on Moderna’s COVID-19 jab; U.K. rolls out AstraZeneca-Oxford’s COVID-19 vaccine Life Science
